Aptose Biosciences (APS) Scheduled to Post Earnings on Tuesday

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 14th. Analysts expect the company to announce earnings of C($1.12) per share for the quarter.

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) last released its quarterly earnings data on Tuesday, March 26th. The biotechnology company reported C($1.96) earnings per share for the quarter, topping analysts’ consensus estimates of C($1.98) by C$0.02.

Aptose Biosciences Stock Performance

TSE APS traded up C$0.02 on Tuesday, reaching C$1.71. 4,388 shares of the company’s stock traded hands, compared to its average volume of 9,102. Aptose Biosciences has a fifty-two week low of C$1.59 and a fifty-two week high of C$10.95. The company has a debt-to-equity ratio of 14.27, a quick ratio of 5.41 and a current ratio of 0.78. The firm has a market cap of C$26.86 million, a price-to-earnings ratio of -0.16 and a beta of 1.44. The stock has a 50 day moving average price of C$1.98 and a 200-day moving average price of C$2.77.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.